Picture of Peoplebio logo

304840 Peoplebio Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Peoplebio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4,001-4,383-4,942-15,003-17,382
Depreciation
Amortisation
Non-Cash Items1,379773-1,8033,6412,641
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-294-168-822-3,894-3,106
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2,652-3,494-6,833-13,975-16,282
Capital Expenditures-1.9-205-1,390-1,340-760
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2,957-245-2,578-10,2022,077
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities2,955-450-3,968-11,5421,316
Financing Cash Flow Items692-1.75-544
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-17010,01143,3513502,014
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1336,06732,550-25,166-12,952